Publications

Terry and her colleagues have been researching the effect of natural medicine on MGUS & SMM patients for over a decade now.  This work has been presented  at conferences in Australia, Japan and the USA.  

Below is a list of all her published work:

  1. 2009 - The potential role of curcumin in patients with monoclonal gammopathy of undefined significance – its effect on paraproteinemia and the urinary N-telopeptide of type 1 collagen bone turnover marker.
  2. 2010 - Vitamin D status may effect the skeletal complications of multiple myeloma.
  3. 2011 - The impact of osteoporosis (as measured by lumbar spine quantitative computed tomography) on disease activity and survival in myeloma patients: a 13-year prospective study.
  4. 2012 - Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study.
  5. 2012 - Response to Vermorken et al--curcumin and free light chains.
  6. 2013 - Long term use of curcumin in two smoldering multiple myeloma (SMM) patients.
  7. 2013 - Curcumin enhances the cytotoxic and chemo-sensitising effects of lenalidomide in human multiple myeloma cells.
  8. 2015 - Stabilisation of Laryngeal AL Amyloidosis with Long Term Curcumin Therapy
  9. 2015 - The effect of curcumin (as Meriva) on absolute lymphocyte count (ALC), NK cells and T cell populations in patients with stage 0/1 chronic lymphocytic leukemia.
  10. 2015 - B-Cell Disorders and Curcumin
  11. 2016 - Addition of Rice Bran Arabinoxylan to Curcumin Therapy May Be of Benefit to Patients With Early-Stage B-Cell Lymphoid Malignancies (Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Stage 0/1 Chronic Lymphocytic Leukemia): A Preliminary Clinical Study.
  12. 2017 - Long-term follow-up of curcumin treated MGUS/SMM patients – an updated single centre experience.
  13. 2017 - Evidence-Based Review of BioBran/MGN-3 Arabinoxylan Compound as a Complementary Therapy for Conventional Cancer Treatment.
  14. 2017 - Effect of the Ginger Derivative, 6-Shogaol, on Ferritin Levels in Patients With Low to Intermediate-1-Risk Myelodysplastic Syndrome-A Small, Investigative Study.
  15. 2020 - Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapy.

Contact Me 

MGUS Therapy
Sydney, Australia

Linkedin.png

© 2020 by MGUS Therapy

Disclaimer

The information contained in this site is intended to provide helpful health information. While the site managers have exercised due care in ensuring the accuracy of the material contained on this website, the information is made available on the understanding that the site managers are not providing professional advice on a particular matter. Nothing contained in this site is intended to be used as medical advice and it is not intended to be used to diagnose, treat, cure or prevent any disease, nor should it be used for therapeutic purposes or as a substitute for your own health professional's advice. Before relying on the material in any important matter, users should carefully evaluate its accuracy, currency, completeness and relevance for their purposes, and should obtain any appropriate professional advice relevant to their particular circumstances. In some cases the material may incorporate or summarise views, guidelines or recommendations of third parties. Such material is assembled in good faith, but does not necessarily reflect the considered views of the site managers, or indicate a commitment to a particular course of action. The site managers do not accept any liability for any injury, loss or damage incurred by use of or reliance on the information provided on this website.